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Abstract
Background—In 2009, Thailand recommended pregnant women be prioritized for influenza 
vaccination. Vaccine uptake among Thai pregnant women is lower than other high-risk groups.
Methods—During December 2012-April 2013, we conducted a cross-sectional survey of a 
convenience sample of Thai pregnant women aged ≥15 years attending antenatal clinics at public 
hospitals in 8 of 77 provinces. A self-administered questionnaire covered knowledge, attitudes, 
and beliefs related to influenza vaccination using the Health Belief Model. We examined factors 
associated with willingness to be vaccinated using log-binomial regression models.
Results—The survey was completed by 1,031 (96%) of 1,072 pregnant women approached. A 
total of 627 (61%) women had heard about influenza vaccine and were included in the analysis, of 
whom 262 (42%) were willing to be vaccinated, 155 (25%) had received a healthcare provider 
recommendation for influenza vaccination and 25 (4%) had received the influenza vaccine during 
the current pregnancy. In unadjusted models, high levels of perceptions of susceptibility 
(prevalence ratio [PR] 1.5, 95% CI 1.2–2.0), high levels of belief in the benefits of vaccination (PR 
2.3, 95% CI 1.7–3.1), moderate (PR 1.7, 95% CI 1.2–2.3) and high (PR 3.4, 95% CI 2.6–4.5) 
levels of encouragement by others to be vaccinated (i.e., cues to action) were positively associated 
with willingness to be vaccinated. Moderate (PR 0.5, 95% CI 0.4–0.7) and high levels of (PR 0.5, 
95% CI 0.4–0.8) perceived barriers were negatively associated with willingness to be vaccinated. 
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In the final adjusted model, only moderate (PR 1.5, 95% CI 1.1–2.0) and high levels of cues to 
action (PR 2.7, 95% CI 2.0–3.6) were statistically associated with willingness to be vaccinated.
Conclusion—Cues to action were associated with willingness to be vaccinated and can be used 
to inform communication strategies during the vaccine campaign to increase influenza vaccination 
among Thai pregnant women.
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Introduction
Influenza is an important cause of morbidity and mortality worldwide, and pregnant women 
are at increased risk of severe complications compared with the non-pregnant population [1, 
2]. During the 2009 influenza A(H1N1) pandemic, hospitalized and intubated patients with 
influenza were significantly more likely to be pregnant women compared to community 
controls [3]. The mortality rate among pregnant women from influenza and pneumonia 
during the 2009 pandemic was 2- to 3- fold higher than among non-pregnant women [4–6], 
and women who died were more likely to be pregnant than those who did not [6].
Influenza vaccination is the most effective strategy for preventing illness associated with 
influenza infection and reducing influenza-related complications [7, 8]. Vaccination during 
pregnancy provides benefits to both mother and newborn [9, 10]. A randomized controlled 
trial and a prospective cohort study both found that maternal influenza vaccination was 
effective at preventing laboratory-confirmed influenza in infants up to six months of age, 
who are not yet eligible for influenza vaccination [10, 11]. Maternal vaccination is also 
associated with a reduced risk of influenza-associated hospitalizations in infants less than six 
months old [12, 13].
In 2009, the Thai Advisory Committee on Immunization Practices recommended seasonal 
influenza vaccine for pregnant women in the second and third trimester of pregnancy as a 
high priority group, after which the vaccine was made available free of charge through the 
Universal Coverage Scheme (a national health insurance available to all Thais) [14, 15]. The 
amount of vaccine available is far less than needed for all recommended high risk groups, 
and between 2010 and 2012, coverage of seasonal influenza vaccine in pregnant women was 
less than 1% and far lower than other high risk groups [14]. The reasons for the low uptake 
of influenza vaccine among pregnant women in Thailand are not known, and the knowledge, 
attitudes and health beliefs of pregnant women in Thailand about seasonal influenza 
vaccination have not been investigated extensively. Understanding how these factors affect 
influenza vaccination would improve communication campaigns directed at pregnant 
women’s awareness of the benefits of influenza vaccination and concerns regarding vaccine 
safety. In this evaluation, we identified factors among pregnant women that were associated 
with willingness to receive the seasonal influenza vaccine.
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During December 2012-April 2013, we conducted a cross-sectional survey among a 
convenience sample of pregnant Thai women who attended antenatal clinics (ANCs) at 
public hospitals. In Thailand, the largest influenza virus activity peaks between June and 
October [16] and therefore the influenza vaccine campaign runs between May and 
September each year [14]. We purposively selected seven provinces plus the Bangkok 
Metropolitan Area to draw from the four regions of Thailand (central, northern, southern and 
northeastern). We selected the provincial hospital and three district hospitals from each 
province, and the only government maternity hospital plus three health centers from the 
Bangkok Metropolitan area. We allocated a target number of women for enrolment to each 
hospital and health center in advance with an overall enrolment goal of 1,072 women. The 
ANC clinics are usually open one to two days per week, and surveys were only administered 
on days during which ANC clinics were open. Study staff approached pregnant women who 
visited ANC clinics and obtained verbal consent from all pregnant women before 
administering the survey. Surveys were conducted on multiple days in order to reach the 
sample size for each hospital. Women were eligible for participation if they were of Thai 
nationality, aged ≥15 years, could read and write Thai and provided verbal consent. As the 
survey was evaluating a national public health program, it was considered program 
evaluation and exempted from ethical review by the Thai Ministry of Public Health 
(Nonthaburi, Thailand) and the U.S. Centers for Disease Control and Prevention (Atlanta, 
GA).
The questionnaire requested demographic information, history of previous influenza 
vaccination and knowledge of influenza virus infection and vaccination. Questions related to 
attitudes towards influenza vaccination were based on the Health Belief Model (HBM) 
which includes five constructs that influence health behaviors, namely perceptions of 
susceptibility, severity, barriers, benefits, and cues to action [17]. The HBM posits that 
people are likely to exhibit disease prevention behaviors (such as vaccination) if they 
perceive that they are susceptible to the disease, the disease is severe, the behavior is 
beneficial, and barriers are minimal [18]. In addition, cues to action, such as 
recommendations of health care providers or health messages, can affect behaviors. We 
adapted and modified questions from previous published literature [18, 19] and translated 
them into the Thai language. Two statements in the questionnaire focused on perceived 
susceptibility to getting influenza for both mother and infant; two on perceived severity of 
influenza infection for mother and infant; three on perceived barriers of influenza vaccine; 
three on perceived benefits of the vaccine; and five on cues to action (i.e., encouragement by 
others to be vaccinated).
Participants who had never heard of the influenza vaccine were excluded from analysis of 
factors affecting vaccination since our study was designed to assess pre-existing attitudes 
towards influenza vaccination. Among the women who had heard of the influenza vaccine, 
those who reported having received an influenza vaccine or reported that they wanted to get 
the influenza vaccine during their current pregnancy were considered willing to be 
vaccinated. We grouped response answer for HBM individual items into two groups: 1) 
agree, or 2) disagree or don’t know/not sure. Participants’ level of concern about their 
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personal susceptibility to influenza during this pregnancy and their unborn child’s 
susceptibility were categorized as 1) moderate or very concerned, or 2) little or not 
concerned or don’t know. We compared the proportion of women who agreed with the 
statements or were moderately or very concerned between women willing and unwilling to 
be vaccinated using a Chi-square test.
Individual HBM items were re-coded to three levels (Supplemental Table 1) such that higher 
values corresponded to a greater degree of agreement or importance as: 1 = unlikely, low or 
disagree; 2 = uncertain or moderate, and 3 = likely, high or agree [20]. The individual HBM 
items were combined based on conceptual similarity into HBM constructs and then summed 
to create scores for each component of the HBM framework. In order to facilitate 
interpretation, participants were divided into tertiles by their summed score to create three 
(low/moderate/high) categories for each HBM construct, with the exception of perceived 
severity which was scored dichotomously (low/high) given the high kurtosis (peakedness) of 
the distribution [20].
The associations between demographic characteristics and HBM constructs with willingness 
to be vaccinated were analyzed using a log-binomial model with a generalized estimating 
equations approach. Standard errors were adjusted for data clustered by hospital using a 
robust sandwich estimator with an exchangeable correlation structure; prevalence ratios (PR) 
and 95% confidence intervals (CI) were calculated. All HBM constructs plus any patient 
characteristic variables statistically associated with willingness to be vaccinated (P<0.05) 
were included in the multivariable modeling process, although variables highly correlated 
with the outcome (such as previous history of vaccination) were excluded. Model selection 
proceeded by backward step selection to identify the set of parameters that minimized the 
quasi-likelihood information criterion [21]. All statistical analyses were performed with 
SPSS (IBM SPSS Statistic 20).
Results
Demographic characteristics of pregnant women and willingness to be vaccinated
Of 1,072 pregnant women approached from 32 facilities, 1,031 (96%) completed the 
questionnaire. Of these 1,031 women, 627 (61%) had heard about the influenza vaccine and 
were considered the analytical sample (Figure 1). Women who had heard about the influenza 
vaccine were more likely to be educated (PR 1.7, 95% CI 1.4–2.0), aged 25–34 years (PR 
1.495% CI 1.3–1.6), aged 35–45 years (PR 1.4 95% CI 1.2–1.6), have universal health 
insurance (PR 1.8, 95% CI 1.2–2.7), have received influenza vaccine during a previous 
pregnancy (PR 1.3, 95% CI 1.2–2.7), and have received influenza vaccine during the current 
pregnancy (PR 1.3, 95% CI 1.2–1.5) than women who had not heard of the vaccine 
(Supplemental table 2).
Among women familiar with influenza vaccine, the median age was 27 years (inter-quartile 
range [IQR] 22–31 years) and median gestational age at time of interview was 28 weeks 
(IQR 17–35 weeks). The average household income in our survey was 15,767 Thai Baht per 
month (493 U.S. dollars) and almost half of participants were earning less than 10,000 Baht 
(313 U.S. dollars) per month. Most of the participants were married (97%), 50% worked 
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outside the home, and 98% had health insurance through the Universal Coverage Scheme. 
Sixty-three (10%) pregnant women had received influenza vaccine during a previous 
pregnancy and 25 (4%) had received it during their current pregnancy.
Two hundred and sixty-two (42%) women reported being willing to receive the seasonal 
influenza vaccine (Figure 1). Most demographic characteristics were similar between 
women willing and not willing to receive the influenza vaccination (Table 1), but women 
who had received an influenza vaccine during a previous pregnancy were twice as likely to 
be willing to receive an influenza vaccine during the current pregnancy (PR 2.1, 95% CI 
1.8–2.5).
Health beliefs of pregnant women and willingness to be vaccinated
Perceived susceptibility to influenza, severity of influenza, benefits of influenza vaccine and 
cues to action were higher among women who were willing to be vaccinated than those who 
were not (Table 2). Among women willing to be vaccinated, 42% perceived themselves as 
susceptible to influenza compared with 28% of women unwilling to be vaccinated 
(P<0.001). A greater proportion of pregnant women who were willing to be vaccinated than 
those not willing believed the influenza vaccine would protect their unborn child (78% vs. 
52%, P<0.001) or themselves (83% vs 53%, P<0.001). Women willing to be vaccinated 
were much more likely than women unwilling to be vaccinated to respond to cues to action 
to be vaccinated from the MOPH (74% vs. 34%, P<0.001), relatives (59% vs. 20%, 
P<0.001), husband (60% vs. 20%, P<0.001), nurse (77% vs. 49%, P<0.001) and physicians 
(87% vs. 65%, P<0.001).
In univariate models, high levels of perceived susceptibility of influenza illness, high levels 
of perceived benefits of vaccination, and moderate and high levels of cues to action were 
positively associated with willingness to receive the influenza vaccine, while perceived 
barriers of vaccination were negatively associated with willingness to be vaccinated in 
pregnant women (Table 3). In the final model, moderate (PR 1.5 95% CI 1.1–2.0) and high 
(PR 2.7 95% CI 2.0–3.6) level of cues to action were statistically associated with willingness 
to be vaccinated (Table 3).
Discussion
We surveyed pregnant women receiving antenatal care at public clinics in Thailand as part of 
a national influenza vaccine program evaluation. Our evaluation suggests that two out of 
three pregnant women had heard about the influenza vaccine but <5% of women who had 
heard about the vaccine received it during their current pregnancy. Although vaccine uptake 
was low, 42% of women who were familiar with the influenza vaccine said they would be 
willing to be vaccinated. Cues to action such as recommendations for vaccination from 
healthcare providers, relatives and husbands were independently associated with willingness 
to be vaccinated among Thai pregnant women after adjusting for other variables. Although 
in univariate models, perceived susceptibility to influenza and perceived benefits to 
influenza vaccination were associated with greater willingness to be vaccinated in pregnant 
women, and perceived barriers were associated with lower willingness to be vaccinated, 
these associations were no longer statistically significant after adjusting cues to action.
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Although the Thai Advisory Committee on Immunization Practices expanded influenza 
vaccine recommendations to include pregnant women as a high priority group in 2009, 
seasonal influenza vaccine coverage among Thai pregnant women was reported to be only 
0.9–1.1% during 2010–2012, and much lower than other high risk groups [14]. Vaccination 
coverage among Thai pregnant women may be low for several reasons. First, access may be 
insufficient, since national influenza vaccine supplies are limited and are determined by 
estimates of the number of persons with chronic diseases without accounting for pregnant 
women as a separate risk group. Each year, the Thai government purchases 3.5 million doses 
of vaccine, whereas the population of Thailand is 66 million with approximately 10 million 
persons with chronic disease and 700,000 pregnant women.[14]. Thus, the government may 
wish to consider the number of pregnant women each year when purchasing influenza 
vaccine to increase influenza vaccine coverage. Second, we found that healthcare provider 
recommendations were an important cue to action for influenza vaccine acceptance among 
Thai pregnant women, but only 25% of pregnant women had received a healthcare provider 
recommendation for influenza vaccination. Improving access to influenza vaccines by 
increasing the supply of government-funded vaccine available each year and increasing 
healthcare provider awareness of the importance of recommending influenza vaccination to 
pregnant women might increase vaccination coverage rates among Thai pregnant women.
HBM theory provides a valuable framework for evaluating factors associated with 
vaccination behavior. Using the HBM model, we found that cues to action were the most 
important factors associated with willingness to receive influenza vaccine. Prior studies have 
identified healthcare providers’ recommendations as an important cue to action for pregnant 
women to receive influenza vaccine [22, 23]. A study by Geraldine and colleagues (2011) 
demonstrated that the factors associated with higher rate of vaccination during the influenza 
A(H1N1) 2009 pandemic were vaccination occurring toward the end of pregnancy, and 
confidence in advice offered by health professionals [23]. In our study population, a 
recommendation for vaccination from a family member or husband was also an important 
cue to action suggesting that vaccination campaigns could also target family members as 
well as pregnant women themselves in order to increase vaccination coverage.
Surprisingly, after accounting for cues to action, potential barriers to influenza vaccination, 
including safety concerns and lack of confidence in the effectiveness of the vaccine, were 
not important predictors of willingness to be vaccinated in our survey. This finding is in 
contrast with several previous studies of pregnant women conducted in Western countries 
[24–26]. In the Georgia Pregnancy Risk Assessment and Monitoring System, unvaccinated 
respondents cited a variety of reasons for not receiving the influenza vaccine including 
worries that the vaccine might harm their babies (27%) or themselves (26%) [27]. Similarly, 
in a cross-sectional survey of pregnant women at an academic, tertiary care hospital in 
Pennsylvania, 61% of the women reported concern about vaccine safety during pregnancy 
and 8% reported the belief that the influenza vaccine caused influenza [28]. As perceived 
barriers were associated with lower willingness to be vaccinated in univariate models, it is 
likely that confidence in recommendations of healthcare providers and family members 
overrides any personal concerns about safety or effectiveness.
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Our evaluation had several limitations. First, the survey was not a probability sample, and 
therefore it is unclear how representative the sample is of the pregnant Thai population. Our 
finding of a much higher rate of vaccination in this sample than in national estimates 
suggests that our sample was more interested and knowledgeable of the influenza vaccine 
than the general population. Second, our evaluation was conducted only in public hospitals, 
and therefore, our survey population may not be representative of Thai pregnant women who 
receive antenatal care at private hospitals or sub-district hospitals and women who do not 
receive antenatal care. A survey of Health Behaviors during pregnancy and breastfeeding in 
Thailand in 2013 found that 71% pregnant women received antenatal care at public hospital, 
4% at private hospital, 17% at private clinic, and 8% at sub-district health promotion 
hospital [29]. A report from the National Statistics Office found that the proportion of Thai 
pregnant women who received antenatal care at least four times during their pregnancy was 
93% [30]. Finally, our evaluation was not conducted during the influenza vaccine campaign 
period (May to September), so the answers from this survey may not reflect beliefs one 
would encounter during periods when the vaccine is being promoted.
Conclusions
In this survey 39% of pregnant women had never heard of the influenza vaccine and only 
one in 25 received the vaccine during the current pregnancy. Cues to action such as a 
healthcare provider, relative or husband recommendation to get the vaccination were 
important to a pregnant women’s willingness to receive the influenza vaccine. These 
findings suggest that improve communication strategies directed toward pregnant women, 
their families and their providers are needed during vaccine campaigns in Thailand.
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Figure 1. Flow chat of pregnant women survey
aWilling to receive the vaccine: pregnant women who responded “yes” to one of the 
following questions: “Did you receive influenza vaccine during this pregnancy?” or “Do you 
want to get influenza vaccine or not?”
bNot willing to receive the vaccine: pregnant women who responded “no” “not sure” and 
“not now, need more information” to “Do you want to get influenza vaccine or not?”
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Table 1
Descriptive characteristics of pregnant women by willingness to be vaccinated, Thailand, 2013
Factors
Willing to be 
vaccinated N (%) 
(n=262)
Not willing to be 
vaccinated N (%) 
(n=365)
Prevalence Ratio 95 % confidence 
interval
Age (years)
 15–24 116 (44) 133 (36) 1.0 –
 25–34 112 (43) 185 (51) 0.8 0.7–1.0
 35–45 34 (13) 47 (13) 0.9 0.7–1.2
Gestational age (weeks)
 First trimester (1–13 weeks) 47 (18) 59 (16) 1.0 –
 Second trimester (14–27 weeks) 88 (34) 118 (32) 1.0 0.7–1.3
 Third trimester (>27 weeks) 127 (48) 188 (52) 0.9 0.7–1.2
Married 253 (97) 356 (98) 0.8 0.8–1.3
Highest level of education
 None or primary 32 (12) 48 (8) 1.0 –
 Secondary school 174 (66) 222 (61) 1.1 0.8–1.5
 Diploma or higher 56 (21) 95 (26) 0.9 0.7–1.3
Household income <10,000 Baht per month 149 (57) 174 (48) 1.2 1.0–1.5
Work outside of home 120 (45) 193 (53) 1.1 0.9–1.4
Health insurance that covered influenza 
vaccination
257 (98) 356 (98) 1.2 0.6–2.4
Received influenza vaccine during previous 
pregnancy
50 (19) 13 (4) 2.1 1.8–2.5
Received influenza vaccine during current 
Pregnancy
25 (9.5) – – –
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